14 ALS Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting ALS Studies in San Francisco

NCT06578195Recruiting

ASSESS ALL ALS Study

The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS ge...

San Francisco, CA2,000 participantsSt. Joseph's Hospital and Medical Center, Phoenix

View Study Details

NCT04297683Recruiting

HEALEY ALS Platform Trial - Master Protocol

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS....

San Francisco, CAPHASE21,500 participantsMerit E. Cudkowicz, MD

View Study Details

NCT03489278Recruiting

Clinical Procedures to Support Research in ALS

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis ...

San Francisco, CA1,200 participantsUniversity of Miami

View Study Details

NCT06211348Recruiting

Genomic Sequencing in Anatomically Normal Fetuses

This cohort study will examine the clinical utility of genomic sequencing (GS) in patients undergoing prenatal diagnostic procedures (chorionic villus sampling or amniocentesis) for routine indication...

San Francisco, CANA1,000 participantsUniversity of California, San Francisco

View Study Details

NCT06581861Recruiting

PREVENT ALL ALS Study

San Francisco, CA600 participantsSt. Joseph's Hospital and Medical Center, Phoenix

View Study Details

NCT07322003Recruiting

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about the safety of pridopidine. The main questio...

San Francisco, CAPHASE3500 participantsPrilenia

View Study Details

NCT07498426Recruiting

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

This Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants will be randomized to receive either NIO...

San Francisco, CAPHASE3300 participantsNovartis Pharmaceuticals

View Study Details

NCT05407324Recruiting

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

The purpose of this 2-part study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyotrophic Lateral Sclerosis (ALS)....

San Francisco, CAPHASE2279 participantsCorcept Therapeutics

View Study Details

NCT07161999Recruiting

Study of COYA 302 for the Treatment of ALS

The ALSTARS trial will be conducted across 20-25 sites in the US and Canada, and will evaluate the safety and efficacy of an investigational treatment called COYA 302 for adults with Amyotrophic Later...

San Francisco, CAPHASE2120 participantsCoya Therapeutics

View Study Details

NCT07142291Recruiting

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

The purpose of this study is to test the effects of PHENOGENE-1A, which is the treatment under investigation in this study. This research will investigate if PHENOGENE-1A can help people with ALS by m...

San Francisco, CAPHASE2105 participantsPhenoNet, Inc.

View Study Details

NCT06527222Recruiting

A Study of Ranolazine in ALS

The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS....

San Francisco, CAPHASE272 participantsSwathy Chandrashekhar, MBBS

View Study Details

NCT05395624Recruiting

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP-801 is intended as a biomarker for PET imaging of activated...

San Francisco, CAPHASE165 participantsAshvattha Therapeutics, Inc.

View Study Details

NCT06122675Recruiting

Cerebellar Deep Brain Stimulation for Movement Disorders in Cerebral Palsy in Children and Young Adults

The purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat...

San Francisco, CANA10 participantsUniversity of California, San Francisco

View Study Details

NCT03698149Recruiting

ECoG BMI for Motor and Speech Control

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders....

San Francisco, CANA3 participantsKarunesh Ganguly

View Study Details

About ALS Clinical Trials in San Francisco

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects motor neurons controlling voluntary muscle movement. Also known as Lou Gehrig's disease, it leads to increasing paralysis. Research is actively pursuing disease-modifying treatments and gene therapies.

There are currently 14 als clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 7,754 participants. Research is being sponsored by St. Joseph's Hospital and Medical Center, Phoenix, Merit E. Cudkowicz, MD, University of Miami and 9 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ALS Clinical Trials in San Francisco — FAQ

Are there als clinical trials in San Francisco?

Yes, there are 14 als clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What als treatments are being tested?

The 14 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for als.

Data updated July 18, 2026 from ClinicalTrials.gov